| Autor: |
Yumiko Tsushima, Keren Zhou, James F. Bena, Sangeeta R. Kashyap |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Endocrine Practice. 28:378-383 |
| ISSN: |
1530-891X |
| DOI: |
10.1016/j.eprac.2022.01.008 |
| Popis: |
To determine the prevalence of obesity and assess the cardiometabolic risk profile and treatments associated with obesity management in the type 1 diabetes mellitus adult population.We reviewed the records of all patients with type 1 diabetes mellitus seen in our institution's outpatient endocrinology clinic between 2015 and 2018. We stratified the patients into 4 weight categories on the basis of body mass index (BMI) (normal, overweight, obesity class I, and combined obesity class II and III) and evaluated their associated clinical characteristics and relevant medications.Of 451 patients, 64% had a BMI of25 kg/mObesity was prevalent in a population of patients with type 1 diabetes mellitus seen in a specialty clinic. Those with obesity had a higher prevalence of cardiovascular disease than their normal weight counterparts. The use of weight loss medications was scarce. Studies exploring the safety and efficacy of obesity-targeted therapy in the type 1 diabetes mellitus population are needed. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
